Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10749)
All Articles published online
|
Aug 14, 2012 (publication date) through Feb 14, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tonus C, Sellinger M, Koss K, Neupert G. Faecal pyruvate kinase isoenzyme type M2 for colorectal cancer screening: A meta-analysis. World J Gastroenterol 2012; 18(30): 4004-4011 [PMID: 22912551 DOI: 10.3748/wjg.v18.i30.4004] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i30/4004.htm |
| Number | Citing Articles |
| 1 |
James R. Bailey, Ashish Aggarwal, Thomas F. Imperiale. Colorectal Cancer Screening: Stool DNA and Other Noninvasive Modalities. Gut and Liver 2016; 10(2): 204 doi: 10.5009/gnl15420
|
| 2 |
Nasimeh Vatandoost, Jahanafrooz Ghanbari, Mahboobeh Mojaver, Amir Avan, Majid Ghayour-Mobarhan, Reza Nedaeinia, Rasoul Salehi. Early detection of colorectal cancer: from conventional methods to novel biomarkers. Journal of Cancer Research and Clinical Oncology 2016; 142(2): 341 doi: 10.1007/s00432-015-1928-z
|
| 3 |
Zongwei Li, Peng Yang, Zhuoyu Li. The multifaceted regulation and functions of PKM2 in tumor progression. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2014; 1846(2): 285 doi: 10.1016/j.bbcan.2014.07.008
|
| 4 |
Fabrizio Maria Gili, Luca Cabianca, Gian Paolo Caviglia. Utilizzo del test per la quantificazione dell’M2-PK fecale nell’ambito di un programma di screening per il carcinoma colorettale in soggetti positivi al FIT. La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine 2016; 12(2): 119 doi: 10.1007/s13631-016-0120-z
|
| 5 |
Divya B. Bhatt, Valerie-Sue Emuakhagbon. Current Trends in Colorectal Cancer Screening. Current Colorectal Cancer Reports 2019; 15(2): 45 doi: 10.1007/s11888-019-00432-4
|
| 6 |
Paul Dowling, David J. Hughes, Anne Marie Larkin, Justine Meiller, Michael Henry, Paula Meleady, Vincent Lynch, Barbara Pardini, Alessio Naccarati, Miroslav Levy, Pavel Vodicka, Paul Neary, Martin Clynes. Elevated levels of 14-3-3 proteins, serotonin, gamma enolase and pyruvate kinase identified in clinical samples from patients diagnosed with colorectal cancer. Clinica Chimica Acta 2015; 441: 133 doi: 10.1016/j.cca.2014.12.005
|
| 7 |
Mirko Di Ruscio, Filippo Vernia, Antonio Ciccone, Giuseppe Frieri, Giovanni Latella. Surrogate Fecal Biomarkers in Inflammatory Bowel Disease: Rivals or Complementary Tools of Fecal Calprotectin?. Inflammatory Bowel Diseases 2018; 24(1): 78 doi: 10.1093/ibd/izx011
|
| 8 |
Marc Tänzer, Magdalena Liebl, Michael Quante. Molecular biomarkers in esophageal, gastric, and colorectal adenocarcinoma. Pharmacology & Therapeutics 2013; 140(2): 133 doi: 10.1016/j.pharmthera.2013.06.005
|
| 9 |
C. P. Pox. Screening des kolorektalen Karzinoms. coloproctology 2016; 38(2): 141 doi: 10.1007/s00053-015-0080-1
|
| 10 |
Ze Qian, Wendi Hu, Zhen Lv, Hua Liu, Diyu Chen, Yacong Wang, Jian Wu, Shusen Zheng. PKM2 upregulation promotes malignancy and indicates poor prognosis for intrahepatic cholangiocarcinoma. Clinics and Research in Hepatology and Gastroenterology 2020; 44(2): 162 doi: 10.1016/j.clinre.2019.06.008
|
| 11 |
Paolo Battaglia, Elisabetta Baritono, Andrea Remo, Roberto Vendraminelli, Antonio Conti. KRAS Mutations and M2PK Upregulation in Stool Samples from Individuals with Positive Fecal Occult Blood Tests Screened for Colorectal Cancer. Tumori Journal 2014; 100(2): 122 doi: 10.1177/030089161410000202
|
| 12 |
Christian P. Pox. Controversies in Colorectal Cancer Screening. Digestion 2014; 89(4): 274 doi: 10.1159/000363287
|
| 13 |
Yoshikatsu Koga, Nobuyoshi Yamazaki, Yasuhiro Matsumura. New molecular diagnosis and screening methods for colorectal cancer using fecal protein, DNA and RNA. Expert Review of Molecular Diagnostics 2014; 14(1): 107 doi: 10.1586/14737159.2014.863152
|
| 14 |
KhalidAhmad Al-Sindi, MulazimHussain Bukhari, MohmedAli Al-Hamar. Role of a noninvasive stool-based molecular test in screening and early detection of colorectal cancers. Acta Medica International 2019; 6(2): 82 doi: 10.4103/ami.ami_27_19
|
| 15 |
Rashid N. Lui, Sunny H. Wong, Nik Sheng Ding, Masau Sekiguchi, Jun Yu, Tiing‐Leong Ang, Khay‐Guan Yeoh, Han‐Mo Chiu, Joseph J. Y. Sung. Is this the end of colonoscopy screening for colorectal cancer? An Asia‐Pacific perspective. Journal of Gastroenterology and Hepatology 2023; 38(5): 671 doi: 10.1111/jgh.16182
|
| 16 |
Elisabeth Waldmann, Jaroslaw Regula, Monika Ferlitsch. How Can Screening Colonoscopy Be Optimized?. Digestive Diseases 2015; 33(1): 19 doi: 10.1159/000366033
|
| 17 |
Vibhor Gupta, Mohd Askandar Iqbal, Bhupender Kumar, Rameshwar N. K. Bamezai. Tumor Cell Metabolism. 2015; : 123 doi: 10.1007/978-3-7091-1824-5_6
|
| 18 |
Kang-Moon Lee. Fecal Biomarkers in Inflammatory Bowel Disease. Intestinal Research 2013; 11(2): 73 doi: 10.5217/ir.2013.11.2.73
|
| 19 |
Romain Villéger, Amélie Lopès, Julie Veziant, Johan Gagnière, Nicolas Barnich, Elisabeth Billard, Delphine Boucher, Mathilde Bonnet. Microbial markers in colorectal cancer detection and/or prognosis. World Journal of Gastroenterology 2018; 24(22): 2327-2347 doi: 10.3748/wjg.v24.i22.2327
|
| 20 |
Yong Cheol Kim, Jeong Ho Kim, Dae Young Cheung, Tae Ho Kim, Eun Jung Jun, Jung-Whan Oh, Chang Whan Kim, Woo Chul Chung, Byung-Wook Kim, Sung Soo Kim, Jin Il Kim, Soo-Heon Park, Jae Kwang Kim. The Usefulness of a Novel Screening Kit for Colorectal Cancer Using the Immunochromatographic Fecal Tumor M2 Pyruvate Kinase Test. Gut and Liver 2015; 9(5) doi: 10.5009/gnl13457
|
| 21 |
Maru Kim, Hyung-Jin Kim, In Kyu Lee, Seong-Taek Oh, Kyungja Han. Fecal occult blood test/fecal carcinoembriogenic antigen dual rapid test as a useful tool for colorectal cancer screening. European Surgery 2017; 49(3): 127 doi: 10.1007/s10353-017-0464-2
|
| 22 |
Tamara Pang, Steven T Leach, Tamarah Katz, Adam Jaffe, Andrew S Day, Chee Y Ooi. Elevated fecal M2‐pyruvate kinase in children with cystic fibrosis: A clue to the increased risk of intestinal malignancy in adulthood?. Journal of Gastroenterology and Hepatology 2015; 30(5): 866 doi: 10.1111/jgh.12842
|
| 23 |
N. S. Sergeeva, Nina V. Marshutina, Ye. V. Zenkina. Stool immunoassay for identification of colorectal cancer and other significant gastrointestinal diseases risk groups. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2016; 26(2): 50 doi: 10.22416/1382-4376-2016-26-2-50-57
|
| 24 |
Edward Sanders, Svenja Diehl. Analysis and interpretation of transcriptomic data obtained from extended Warburg effect genes in patients with clear cell renal cell carcinoma. Oncoscience 2015; 2(2): 151 doi: 10.18632/oncoscience.128
|
| 25 |
Shahidah Che Alhadi, Wan Zainira Wan Zain, Zalina Zahari, Mohd Nizam Md Hashim, Syed Hassan Syed Abd. Aziz, Zaidi Zakaria, Michael Pak-Kai Wong, Andee Dzulkarnaen Zakaria. The Use of M2-Pyruvate Kinase as a Stool Biomarker for Detection of Colorectal Cancer in Tertiary Teaching Hospital: A Comparative Study. Annals of Coloproctology 2020; 36(6): 409 doi: 10.3393/ac.2020.08.27
|
| 26 |
Petra Hudler, Nina Kocevar, Radovan Komel. Proteomic Approaches in Biomarker Discovery: New Perspectives in Cancer Diagnostics. The Scientific World Journal 2014; 2014: 1 doi: 10.1155/2014/260348
|
| 27 |
Mohd Askandar Iqbal, Vibhor Gupta, Prakasam Gopinath, Sybille Mazurek, Rameshwar N.K. Bamezai. Pyruvate kinase M2 and cancer: an updated assessment. FEBS Letters 2014; 588(16): 2685 doi: 10.1016/j.febslet.2014.04.011
|
| 28 |
Suresh Sithambaram, Ida Hilmi, Khean-Lee Goh, Lanjing Zhang. The Diagnostic Accuracy of the M2 Pyruvate Kinase Quick Stool Test- A Rapid Office Based Assay Test for the Detection of Colorectal Cancer. PLOS ONE 2015; 10(7): e0131616 doi: 10.1371/journal.pone.0131616
|
| 29 |
Chia-Long Lee, Chi-Jung Huang, Shung-Haur Yang, Chun-Chao Chang, Chi-Cheng Huang, Chih-Cheng Chien, Ruey-Neng Yang. Discovery of genes from feces correlated with colorectal cancer progression. Oncology Letters 2016; 12(5): 3378 doi: 10.3892/ol.2016.5069
|
| 30 |
C. P. Pox, F. Kühn, E. Klar. Darmkrebsfrüherkennung. Der Onkologe 2016; 22(8): 529 doi: 10.1007/s00761-016-0048-y
|
| 31 |
Hisham K. Dabbous, Yosry Abd El-Rahman Mohamed, Runia F. El-Folly, Mohamed D. El-Talkawy, Hani E. Seddik, Dina Johar, Mohammed A. Sarhan. Evaluation of Fecal M2PK as a Diagnostic Marker in Colorectal Cancer. Journal of Gastrointestinal Cancer 2019; 50(3): 442 doi: 10.1007/s12029-018-0088-1
|
| 32 |
Abdo Alnabulsi, Graeme I. Murray. Proteomics for early detection of colorectal cancer: recent updates. Expert Review of Proteomics 2018; 15(1): 55 doi: 10.1080/14789450.2018.1396893
|
| 33 |
Sally C. Benton, Helen E. Seaman, Stephen P. Halloran. Faecal Occult Blood Testing for Colorectal Cancer Screening: the Past or the Future. Current Gastroenterology Reports 2015; 17(2) doi: 10.1007/s11894-015-0428-2
|
| 34 |
Jeremy R Huddy, Melody Z Ni, Sheraz R Markar, George B Hanna. Point-of-care testing in the diagnosis of gastrointestinal cancers: Current technology and future directions. World Journal of Gastroenterology 2015; 21(14): 4111-4120 doi: 10.3748/wjg.v21.i14.4111
|
| 35 |
Chiara Rosso, Luca Cabianca, Fabrizio M. Gili. Non-invasive markers to detect colorectal cancer in asymptomatic population. Minerva Biotecnologica 2019; 31(1) doi: 10.23736/S1120-4826.18.02493-X
|
| 36 |
Sarah Cheuk Hei Chan, Jessie Qiaoyi Liang. Advances in tests for colorectal cancer screening and diagnosis. Expert Review of Molecular Diagnostics 2022; 22(4): 449 doi: 10.1080/14737159.2022.2065197
|
| 37 |
Abeer Hammoudi, Fei Song, Karen R. Reed, Rosalind E. Jenkins, Valerie S. Meniel, Alastair J.M. Watson, D. Mark Pritchard, Alan R. Clarke, John R. Jenkins. Proteomic profiling of a mouse model of acute intestinal Apc deletion leads to identification of potential novel biomarkers of human colorectal cancer (CRC). Biochemical and Biophysical Research Communications 2013; 440(3): 364 doi: 10.1016/j.bbrc.2013.08.076
|
| 38 |
Mariann Rutka, Renáta Bor, Anita Bálint, Anna Fábián, Ágnes Milassin, Ferenc Nagy, Zoltán Szepes, Mónika Szűcs, László Tiszlavicz, Klaudia Farkas, Tamás Molnár. Diagnostic Accuracy of Five Different Fecal Markers for the Detection of Precancerous and Cancerous Lesions of the Colorectum. Mediators of Inflammation 2016; 2016: 1 doi: 10.1155/2016/2492081
|
| 39 |
|
| 40 |
Jacqueline I. Keenan, Frank A. Frizelle. Biomarkers to Detect Early-Stage Colorectal Cancer. Biomedicines 2022; 10(2): 255 doi: 10.3390/biomedicines10020255
|